中信建投证券研究发展部医药大健康研究团队一周核心推荐逻辑精选如下:医药行业周度复盘港股医疗器械整体创新性较强,关注估值修复和国际化机会创新药行业最新观点及核心标的更新集采政策优化不再唯低价论,关注估值修复和业绩拐点机会《医药行业周度复盘》回顾医药行业周度表现,本周制药行业表现较好,恒瑞医药、康方生物、礼新医药、丽珠医药和三生制药等企业的产品管线迎来积极进展。后续可持续关注主要公司产品临床研究进展、...
Source Link中信建投证券研究发展部医药大健康研究团队一周核心推荐逻辑精选如下:医药行业周度复盘港股医疗器械整体创新性较强,关注估值修复和国际化机会创新药行业最新观点及核心标的更新集采政策优化不再唯低价论,关注估值修复和业绩拐点机会《医药行业周度复盘》回顾医药行业周度表现,本周制药行业表现较好,恒瑞医药、康方生物、礼新医药、丽珠医药和三生制药等企业的产品管线迎来积极进展。后续可持续关注主要公司产品临床研究进展、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.